Showing 341 - 360 results of 1,803 for search '"Cardiovascular disease"', query time: 0.07s Refine Results
  1. 341
  2. 342
  3. 343
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355
  16. 356

    Feasibility analysis of non-electrocardiogram-triggered chest low-dose computed tomography using a kV-independent reconstruction algorithm for predicting cardiovascular disease risk in patients receiving maintenance hemodialysis by Xiangming Wang, Ao Liu, Yan Zhao, Xianbo Yu, Yushuo Cao, Min Li, Jing Liu, Yu Du, Li Yang

    Published 2025-01-01
    “…Abstract Objectives This study aimed to evaluate the feasibility and accuracy of non-electrocardiogram (ECG)-triggered chest low-dose computed tomography (LDCT) with a kV-independent reconstruction algorithm in assessing coronary artery calcification (CAC) degree and cardiovascular disease risk in patients receiving maintenance hemodialysis (MHD). …”
    Get full text
    Article
  17. 357

    Healthy enough to work up to age 67 and beyond? A longitudinal population-based study on time trends in working life expectancy free of cardiovascular diseases based on German health insurance data by Fabian Tetzlaff, Jelena Epping, Juliane Tetzlaff, Lieselotte Mond

    Published 2024-04-01
    “…In this study, time trends in working life expectancy (WLE) free of widespread cardiovascular diseases (CVD) as well as the proportion of CVD-free working life years are reported.Methods Claims data from a German statutory health insurance provider is used to analyse CVD-free WLE. …”
    Get full text
    Article
  18. 358

    Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial by Harold Bays, Pingjin Gao, Birgit Völker, Michaela Mattheus, Luis M. Ruilope, Dingliang Zhu

    Published 2013-01-01
    “…Report of prespecified and post hoc subgroup analyses of a randomized, controlled trial comparing telmisartan 80 mg/hydrochlorothiazide 25 mg (T80/H25) combination therapy with T80 monotherapy, according to the presence of cardiovascular disease (CVD) risk factors. Methods. Hypertensive patients were randomized (2 : 1) to receive T80/H25 or T80 for 6 weeks, following a 1-week, low-dose, and run-in period. …”
    Get full text
    Article
  19. 359
  20. 360